Capital Fund Management (CFM)
EXAS

Capital Fund Management (CFM)’s Exact Sciences EXAS Stock Holding History

Capital Fund Management (CFM)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,100
Closed -$1.75M – 2109
2024
Q4 		$1.75M Sell
31,100
-36,200
-54% -$2.25M ﹤0.01% 1546
2024
Q3 		$4.58M Sell
67,300
-10,100
-13% -$570K 0.01% 1062
2024
Q2 		$3.27M Buy
77,400
+18,400
+31% +$1.01M 0.01% 1163
2024
Q1 		$4.07M Sell
59,000
-85,200
-59% -$5.39M 0.01% 1147
2023
Q4 		$10.7M Buy
144,200
+90,900
+171% +$5.96M 0.03% 746
2023
Q3 		$3.64M Buy
+53,300
New +$4.52M 0.01% 1098
2019
Q3 		– Sell
-7,300
Closed -$862K – 1735
2019
Q2 		$862K Buy
+7,300
New +$736K 0.01% 1059
2018
Q4 		– Sell
-41,600
Closed -$3.28M – 1957
2018
Q3 		$3.28M Buy
41,600
+28,900
+228% +$1.88M 0.02% 923
2018
Q2 		$759K Buy
+12,700
New +$683K ﹤0.01% 1439
2017
Q4 		– Sell
-4,900
Closed -$231K – 1842
2017
Q3 		$231K Buy
+4,900
New +$197K ﹤0.01% 1402

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s EXAS Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 82,933 shares — an estimated $4.41M sold.

Capital Fund Management (CFM) first reported a position in EXAS in Q2 2015 and held it in 12 quarters. The position peaked at $10.1M in Q1 2018. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 82,933 Exact Sciences shares in Q3 2025, an estimated $4.41M.
  • Capital Fund Management (CFM) first reported a position in Exact Sciences in Q2 2015 and held it in 12 quarters.
  • Capital Fund Management (CFM)'s Exact Sciences position peaked at $10.1M in Q1 2018.
  • 568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.